Women's health has historically been under-researched, undervalued, and underserved, leading to growing concerns about the impacts of gender on health outcomes. Decades of insufficient investment have resulted in women often receiving delayed, ineffective, and at times harmful treatments. While there have been initiatives to address these inequities in recent years, significant barriers remain in effectively integrating women's health into research and its translation.

To enhance health outcomes for women, it is essential to better understand these gaps and the systematic, large-scale changes needed in the health and medical research landscape—covering aspects such as funding, conducting research, and translating findings into practice.

Research Australia is supported by Besins Healthcare to establish a women's research agenda for Australia, leveraging existing expertise and the current research landscape to improve the health of women. Activities to date have included a sector survey and desktop review to produce a report and draft agenda.

We are hosting a virtual Expert Roundtable on 20 February from 10:30 AM to 12:30 PM AEDT. This workshop will bring together a diverse group of key stakeholders in women's health, including representatives from research, health systems, industry, and consumer groups. The purpose is to build consensus on the key issues and opportunities identified in the earlier stages of our project and to finalise an agenda for Australian Women's Health Research.

We invite you, or a representative from your organisation, to join us in this critical conversation. Your insights and expertise are invaluable in shaping the future of women's health research and practice in Australia.

This project is guided by Research Australia's principles when working with pharmaceutical and other for-profit organisatons:

1. Non-promotional: The project does not seek to promote or endorse an individual company, product or therapeutic.
2. Value: The outcomes of the project will bring benefit (potential or actual) to all, representing Research Australia's unique position as a voice for the entire HMR pipeline.
3. Independent: The work is conducted with independence and methodological rigor by Research Australia. Opportunity for diverse investment in the work is sought where possible.
4. Collaborative: The work seeks to consult with diverse viewpoints representing all those with a stake in the issue or project.
5. Transparent: Pharmaceutical sponsorship or partnership is acknowledged and communicated clearly to all those involved.

REGISTRATION FOR THIS ROUNDTBALE IS NOW AT CAPACITY. IF YOU ARE WANTING TO REGISTER PLEASE EMAIL SAM.MILLS@RESEARCHAUSTRALIA.ORG